全文获取类型
收费全文 | 1581705篇 |
免费 | 101045篇 |
国内免费 | 3087篇 |
专业分类
耳鼻咽喉 | 21555篇 |
儿科学 | 48755篇 |
妇产科学 | 43128篇 |
基础医学 | 215633篇 |
口腔科学 | 43646篇 |
临床医学 | 131184篇 |
内科学 | 307303篇 |
皮肤病学 | 32316篇 |
神经病学 | 129985篇 |
特种医学 | 65256篇 |
外国民族医学 | 443篇 |
外科学 | 245047篇 |
综合类 | 33689篇 |
现状与发展 | 6篇 |
一般理论 | 521篇 |
预防医学 | 118544篇 |
眼科学 | 35452篇 |
药学 | 113805篇 |
4篇 | |
中国医学 | 3796篇 |
肿瘤学 | 95769篇 |
出版年
2018年 | 34073篇 |
2017年 | 27276篇 |
2016年 | 30375篇 |
2015年 | 14549篇 |
2014年 | 20027篇 |
2013年 | 29267篇 |
2012年 | 44606篇 |
2011年 | 59586篇 |
2010年 | 40877篇 |
2009年 | 33783篇 |
2008年 | 56162篇 |
2007年 | 61216篇 |
2006年 | 42063篇 |
2005年 | 42196篇 |
2004年 | 41768篇 |
2003年 | 41417篇 |
2002年 | 38862篇 |
2001年 | 66460篇 |
2000年 | 68248篇 |
1999年 | 57820篇 |
1998年 | 15874篇 |
1997年 | 14472篇 |
1996年 | 13858篇 |
1995年 | 13005篇 |
1994年 | 12206篇 |
1992年 | 44339篇 |
1991年 | 42759篇 |
1990年 | 41986篇 |
1989年 | 40874篇 |
1988年 | 38173篇 |
1987年 | 37461篇 |
1986年 | 35897篇 |
1985年 | 34071篇 |
1984年 | 25502篇 |
1983年 | 21685篇 |
1982年 | 13022篇 |
1981年 | 11868篇 |
1979年 | 24492篇 |
1978年 | 17408篇 |
1977年 | 15125篇 |
1976年 | 13604篇 |
1975年 | 15512篇 |
1974年 | 18364篇 |
1973年 | 17841篇 |
1972年 | 17077篇 |
1971年 | 15960篇 |
1970年 | 15114篇 |
1969年 | 14539篇 |
1968年 | 13671篇 |
1967年 | 12157篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
We evaluated the acquisition and performance of a high-precision locomotor task in patients with Parkinson's disease (PD) and healthy subjects. All subjects walked on a treadmill and had to step repetitively as low as possible over an obstacle without touching it. During blocks 1 and 2, the subjects had full vision and received additional acoustic warning and feedback signals. During block 3, vision became restricted. Changes in foot clearance and the number of obstacle hits were evaluated. Initially, PD patients performed poorer and improved foot clearance slower. After task repetition, the groups performed similarly. Restricting vision deteriorated performance in both groups. The similar performance of PD patients after task repetition might indicate that adequate training could improve adaptive locomotor behavior in PD patients. 相似文献
72.
R H Green C E Brightling S McKenna B Hargadon N Neale D Parker C Ruse I P Hall I D Pavord 《The European respiratory journal》2006,27(6):1144-1151
There is increasing evidence that the assessment of eosinophilic airway inflammation using induced sputum and measurement of airway hyperresponsiveness provides additional, clinically important information concerning asthma control. The aim of this study was to directly compare the effects of different treatments on these markers in patients with asthma and persistent symptoms, despite the use of low-dose inhaled corticosteroids. A double-blind four-way crossover study was performed, which compared a 1-month treatment with budesonide 400 mug b.i.d., additional formoterol, additional montelukast and placebo in 49 patients with uncontrolled asthma despite budesonide 100 mug b.i.d., with each treatment separated by a 4-week washout period. The change in sputum eosinophil count with formoterol (2.4 to 3.8% change, 0.6-fold reduction, 95% confidence interval (CI) 0.5-0.9) differed significantly from placebo (2.8 to 2.5% change, 1.1-fold reduction, 95% CI 0.7-1.6) and high-dose budesonide (2.7 to 1.6% change, 1.6-fold reduction, 95% CI 1.2-2.2). The effects of montelukast did not differ from placebo. The changes in methacholine airway responsiveness were small and did not differ between treatments. High-dose budesonide had the broadest range of beneficial effects on other outcomes, including symptom scores, morning peak expiratory flow and forced expiratory volume in one second. In conclusion, treatment given in addition to low-dose inhaled corticosteroids results in modest benefits. Formoterol and high-dose budesonide have contrasting effects on eosinophilic airway inflammation. 相似文献
73.
C T Gan G P McCann J T Marcus S A van Wolferen J W Twisk A Boonstra P E Postmus A Vonk-Noordegraaf 《The European respiratory journal》2006,28(6):1190-1194
The aim of the current study was to investigate whether alterations in N-terminal pro brain natriuretic peptide (NT-proBNP) reflect changes in right ventricular structure and function in pulmonary hypertension patients during treatment. The study consisted of 30 pulmonary hypertension patients; 15 newly diagnosed and 15 on long-term treatment. NT-proBNP, right heart catheterisation and cardiac magnetic resonance imaging measurements were performed, at baseline and follow-up. There were no significant differences between newly diagnosed patients and those on treatment at baseline or follow-up with respect to NT-proBNP, haemodynamics and right ventricular parameters. Relative changes in NT-proBNP during treatment were correlated to the relative changes in right ventricular end-diastolic volume index (r = 0.59), right ventricular mass index (r = 0.62) and right ventricular ejection fraction (r = -0.81). N-terminal pro brain natriuretic peptide measurements reflect changes in magnetic resonance imaging-measured right ventricular structure and function in pulmonary hypertension patients. An increase in N-terminal pro brain natriuretic peptide over time reflects right ventricular dilatation concomitant to hypertrophy and deterioration of systolic function. 相似文献
74.
75.
C. Ballet G. Roussey-Kesler J.-T. Aubin S. Brouard M. Giral P. Miqueu S. Louis S. van der Werf J.-P. Soulillou 《American journal of transplantation》2006,6(11):2796-2801
Rare kidney allograft recipients enjoy unaltered graft function years after interruption of their immunosuppressive treatment. To assess the extent to which this state of 'operational tolerance' (TOL) is specific to the graft and not the result of a global immunodeficiency, we analyzed the response of such patients following influenza vaccination. Hemagglutination inhibition titers and frequency of IFNgamma-secreting T cells were measured before 1 and 3 months after vaccination. The proportion of healthy volunteers (HV) responding to vaccine was significantly higher than that of immunosuppressed (IS) patients. Three 'TOL' patients presented a humoral response similar to that of HV, whereas the two others had a poor response, like the IS recipients. Although the small number of patients does not allow for definitive conclusions to be made, these data suggest that the status of tolerance may be heterogeneous, with some patients with a global immunodeficiency and others with an adapted response to vaccination. 相似文献
76.
Chan C. H. Y Ng E. H. Y Chan C. L W 《世界核心医学期刊文摘》2006,2(6):15-15
目的:评价东部身体-智力-精神(EBMS)群体干预对进行体外受精(IVF)的中国妇女焦虑缓解的作用。设计:随机对照研究。机构:三级辅助生殖机构。受试者:227例接受第1个IVF周期治疗的妇女。干预:干预组(n=69)接受4次EBMS群体咨询,而对照组(n=115)无任何干预。主要观察指标:状态-特质焦虑问卷。结果:与对照组相比,干预组在干预后状态焦虑平均分显著下降。每组移植同样数目的卵子,但干预组没有明显更高妊娠率的倾向。 相似文献
77.
78.
79.
80.
Sami S Zoghbi H Umesha Shetty Masanori Ichise Masahiro Fujita Masao Imaizumi Jeih-San Liow Jay Shah John L Musachio Victor W Pike Robert B Innis 《Journal of nuclear medicine》2006,47(3):520-527
18F-2beta-Carbomethoxy-3beta-(4-chlorophenyl)-8-(2-fluoroethyl)nortropane (18F-FECNT), a PET radioligand for the dopamine transporter (DAT), generates a radiometabolite that enters the rat brain. The aims of this study were to characterize this radiometabolite and to determine whether a similar phenomenon occurs in human and nonhuman primate brains by examining the stability of the apparent distribution volume in DAT-rich (striatum) and DAT-poor (cerebellum) regions of the brain. METHODS: Two rats were infused with 18F-FECNT and sacrificed at 60 min. Extracts of brain and plasma were analyzed by high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometric (LC-MS) techniques. Two human participants and 3 rhesus monkeys were injected with 18F-FECNT and scanned kinetically, with serial arterial blood analysis. RESULTS: At 60 min after the injection of rats, 18F-FECNT accumulated to levels about 7 times higher in the striatum than in the cortex and cerebellum. The radiometabolite was distributed at equal concentrations in all brain regions. The LC-MS techniques identified N-dealkylated FECNT as a major metabolite in the rat brain, and reverse-phase HPLC detected an equivalent amount of radiometabolite eluting with the void volume. The radiometabolite likely was 18F-fluoroacetaldehyde, the product expected from the N-dealkylation of 18F-FECNT, or its oxidation product, 18F-fluoroacetic acid. The distribution volume in the cerebellum increased up to 1.7-fold in humans between 60 and 300 min after injection and 2.0 +/- 0.1-fold (mean +/- SD; n = 3) in nonhuman primates between 60 and 240 min after injection. CONCLUSION: An 18F-fluoroalkyl metabolite of 18F-FECNT originating in the periphery confounded the measurements of DAT in the rat brain with a reference tissue model. Its uniform distribution across brain regions suggests that it has negligible affinity for DAT (i.e., it is an inactive radiometabolite). Consistent with the rodent data, the apparent distribution volume in the cerebellum of both humans and nonhuman primates showed a continual increase at late times after injection, a result that may be attributed to entry of the radiometabolite into the brain. Thus, reference tissue modeling of 18F-FECNT will be prone to more errors than analysis with a measured arterial input function. 相似文献